APA (7th ed.) Citation

T, S., H, Y., W, W., Y, G., S, X., J, G., & C, Y. (2026). Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines. International journal of nanomedicine, 21, 603396. https://doi.org/10.2147/IJN.S603396

Chicago Style (17th ed.) Citation

T, Shi, Yue H, Wang W, Gao Y, Xu S, Gao J, and Yin C. "Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines." International Journal of Nanomedicine 21 (2026): 603396. https://doi.org/10.2147/IJN.S603396.

MLA (9th ed.) Citation

T, Shi, et al. "Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines." International Journal of Nanomedicine, vol. 21, 2026, p. 603396, https://doi.org/10.2147/IJN.S603396.